283 related articles for article (PubMed ID: 30587528)
1. Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.
Kumar SK; Buadi FK; Rajkumar SV
Blood; 2019 Feb; 133(7):652-659. PubMed ID: 30587528
[TBL] [Abstract][Full Text] [Related]
2. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C
Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719
[TBL] [Abstract][Full Text] [Related]
3. The role of tandem stem cell transplantation for multiple myeloma patients.
Martino M; Recchia AG; Fedele R; Neri S; Vincelli ID; Moscato T; Gentile M; Morabito F
Expert Opin Biol Ther; 2016; 16(4):515-34. PubMed ID: 26698133
[TBL] [Abstract][Full Text] [Related]
4. Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.
Parrish C; Morris CTCM; Williams CD; Cairns DA; Cavenagh J; Snowden JA; Ashcroft J; Cavet J; Hunter H; Bird JM; Chalmers A; Brown JM; Yong K; Schey S; Chown S; Cook G;
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1009-1016. PubMed ID: 26827659
[TBL] [Abstract][Full Text] [Related]
5. All transplantation-eligible patients with myeloma should receive ASCT in first response.
Moreau P; Attal M
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):250-4. PubMed ID: 25696863
[TBL] [Abstract][Full Text] [Related]
6. Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?
Richardson PG; Laubach JP; Munshi NC; Anderson KC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):255-61. PubMed ID: 25696864
[TBL] [Abstract][Full Text] [Related]
7. Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies.
Parrondo RD; Ailawadhi S; Sher T; Chanan-Khan AA; Roy V
JCO Oncol Pract; 2020 Feb; 16(2):56-66. PubMed ID: 32045556
[TBL] [Abstract][Full Text] [Related]
8. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
Cowan AJ; Stevenson PA; Libby EN; Becker PS; Coffey DG; Green DJ; Hyun TS; Fromm JR; Gopal AK; Holmberg LA
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1386-1391. PubMed ID: 29481870
[TBL] [Abstract][Full Text] [Related]
9. Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma.
Laubach J; Kumar S
Cancer Treat Res; 2016; 169():145-167. PubMed ID: 27696262
[TBL] [Abstract][Full Text] [Related]
10. Is there still a role for stem cell transplantation in multiple myeloma?
Mina R; Lonial S
Cancer; 2019 Aug; 125(15):2534-2543. PubMed ID: 30985927
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma: Role of autologous transplantation.
Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Terpos E; Dimopoulos MA
Cancer Treat Rev; 2020 Jan; 82():101929. PubMed ID: 31770695
[TBL] [Abstract][Full Text] [Related]
12. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
Gonsalves WI; Buadi FK; Ailawadhi S; Bergsagel PL; Chanan Khan AA; Dingli D; Dispenzieri A; Fonseca R; Hayman SR; Kapoor P; Kourelis TV; Lacy MQ; Larsen JT; Muchtar E; Reeder CB; Sher T; Stewart AK; Warsame R; Go RS; Kyle RA; Leung N; Lin Y; Lust JA; Russell SJ; Zeldenrust SR; Fonder AL; Hwa YL; Hobbs MA; Mayo AA; Hogan WJ; Rajkumar SV; Kumar SK; Gertz MA; Roy V
Bone Marrow Transplant; 2019 Mar; 54(3):353-367. PubMed ID: 29988062
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma.
Rossi G; Falcone AP; Minervini MM; De Cillis GP; De Waure C; Sisti LG; Giambra V; Valente D; Chiello V; Scalzulli PR; Carella AM; Cascavilla N
Cytometry B Clin Cytom; 2019 May; 96(3):195-200. PubMed ID: 30549231
[TBL] [Abstract][Full Text] [Related]
14. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
15. Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy.
Rocchi S; Zannetti BA; Marconi G; Lanza F
Cells; 2024 May; 13(10):. PubMed ID: 38786075
[TBL] [Abstract][Full Text] [Related]
16. Frontline therapy of multiple myeloma.
Moreau P; Attal M; Facon T
Blood; 2015 May; 125(20):3076-84. PubMed ID: 25838345
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
[TBL] [Abstract][Full Text] [Related]
18. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
Garderet L; Iacobelli S; Koster L; Goldschmidt H; Johansson JE; Bourhis JH; Krejci M; Leleu X; Potter M; Blaise D; Koenecke C; Peschel C; Radocha J; Metzner B; Lenain P; Schäfer-Eckart K; Pohlreich D; Grasso M; Caillot D; Einsele H; Ladetto M; Schönland S; Kröger N
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1372-1378. PubMed ID: 29408334
[TBL] [Abstract][Full Text] [Related]
19. Role of autologous bone marrow transplant in multiple myeloma.
Blanes M; de la Rubia J
Curr Opin Oncol; 2012 Nov; 24(6):733-41. PubMed ID: 23079784
[TBL] [Abstract][Full Text] [Related]
20. Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan.
Muta T; Miyamoto T; Kamimura T; Kanda Y; Nohgawa M; Ueda Y; Iwato K; Sasaki O; Mori T; Uchida N; Iida S; Fukuda T; Atsuta Y; Sunami K
Acta Haematol; 2018; 139(1):35-44. PubMed ID: 29339642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]